Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient setting.

@article{Yoon2009ExenatideAT,
  title={Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient setting.},
  author={Nancy M Yoon and Melissa K. Cavaghan and Rocco L. Brunelle and Paris Roach},
  journal={Clinical therapeutics},
  year={2009},
  volume={31 7},
  pages={1511-23}
}
BACKGROUND Exenatide is an antidiabctic agent currently indicated as adjunctive therapy with oral agents for the treatment of type 2 diabetes mellitus (T2DM). Limited published data exist on the off-label use of exenatide in conjunction with insulin in the treatment of T2DM. OBJECTIVE The aim of this retrospective study was to examine the effects of exenatide on glycemic control, weight, and insulin dose in patients with T2DM treated with insulin. METHODS Patients with T2DM receivirg… CONTINUE READING